WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Hendrik Feys
500 Points

Contributions by role

Editor 500

Contributions by subject area

Biochemistry
Biophysics
Computational Biology
Gynecology and Obstetrics
Hematology
Global Health
Translational Medicine
Emergency and Critical Care
Pediatrics
Nursing
Public Health

Hendrik B. Feys


Summary

Principal Investigator of the Transfusion Research Center, Belgian Red Cross Flanders, Belgium. Visiting Professor at Ghent University, Faculty of Medicine.

Biochemistry Hematology Translational Medicine

Past or current institution affiliations

Universiteit Gent

Work details

Principal Investigator

Belgian Red Cross, Flanders
Transfusion Research Center

Visiting Professor

Universiteit Gent
September 2017 - September 2022
Department of Diagnostic Sciences
Research Professor

Websites

  • ResearcherID
  • Google Scholar
  • Academia.eu
  • PubMed Search

PeerJ Contributions

  • Edited 4

Academic Editor on

September 5, 2018
Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: a retrospective study
Christian Niederwanger, Tobias Hell, Sophie Hofer, Christina Salvador, Miriam Michel, Bettina Schenk, Benedikt Treml, Mirjam Bachler
https://doi.org/10.7717/peerj.5538 PubMed 30202654
March 30, 2017
Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population
Zongkui Wang, Miaomiao Dou, Xi Du, Li Ma, Pan Sun, Haijun Cao, Shengliang Ye, Peng Jiang, Fengjuan Liu, Fangzhao Lin, Rong Zhang, Changqing Li
https://doi.org/10.7717/peerj.3156 PubMed 28382235
November 18, 2014
Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromes
Salvatore Andrea Mastrolia, Moshe Mazor, Giuseppe Loverro, Vered Klaitman, Offer Erez
https://doi.org/10.7717/peerj.653 PubMed 25426334
July 10, 2014
Computational development of rubromycin-based lead compounds for HIV-1 reverse transcriptase inhibition
Carlos E.P. Bernardo, Pedro J. Silva
https://doi.org/10.7717/peerj.470 PubMed 25071993